Mobile

A 16 week randomised, open labelled, 3 armed, parallel group, treat-to-target trial comparing once daily injection of SIAC 30 (B), SIAC 45 (B) and insulin glargine, all in combination with metformin i...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002476-33

A 16 week randomised, open labelled, 3 armed, parallel group, treat-to-target trial comparing once daily injection of SIAC 30 (B), SIAC 45 (B) and insulin glargine, all in combination with metformin in subjects with type 2 diabetes failing on OAD treatment

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess glucose control with respect to HbA_1c after 16 weeks of treatment with SIAC 30 (B) or SIAC 45 (B) QD or insulin glargine QD, all in combination with metformin, in subjects with type 2 diabetes mellitus, failing on OAD treatment.

Critère d'inclusion

  • Type 2 diabetes mellitus

Liens